New York Life Trust’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-835
Closed -$21K 243
2016
Q4
$21K Buy
+835
New +$19.8K 0.1% 181
2016
Q3
Sell
-204
Closed -$4K 272
2016
Q2
$4K Sell
204
-4,730
-96% -$93.3K 0.02% 242
2016
Q1
$107K Buy
4,934
+2,874
+140% +$56.2K 0.46% 68
2015
Q4
$43K Buy
+2,060
New +$41K 0.18% 150
2015
Q3
Sell
-5,349
Closed -$103K 236
2015
Q2
$103K Buy
5,349
+5,221
+4,079% +$104K 0.43% 100
2015
Q1
$2K Sell
128
-463
-78% -$8.87K 0.01% 213
2014
Q4
$12K Sell
591
-3,716
-86% -$70.1K 0.05% 179
2014
Q3
$84K Buy
+4,307
New +$84.6K 0.35% 115

Other funds holding TER

New York Life Trust's TER Position: Q1 2017 in Review

New York Life Trust sold out of Teradyne (TER) in Q1 2017, closing a stake of 835 shares — an estimated $21K sold.

New York Life Trust first reported a position in TER in Q3 2014 and held it in 8 quarters. The position peaked at $107K in Q1 2016. 356 funds tracked by Wall St. Rank hold TER as of Q1 2017.

  • New York Life Trust reported no remaining Teradyne position as of Q1 2017 after selling out during the quarter.
  • New York Life Trust sold 835 Teradyne shares in Q1 2017, an estimated $21K.
  • New York Life Trust first reported a position in Teradyne in Q3 2014 and held it in 8 quarters.
  • New York Life Trust's Teradyne position peaked at $107K in Q1 2016.
  • 356 funds tracked by Wall St. Rank held Teradyne as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.